Reversal of Ketosis in Type 1 Diabetes Is Not Adversely Affected by SGLT2 Inhibitor Therapy

Abstract

Objective: We have shown that ''euglycemic DKA'' in patients with type 1 diabetes receiving a sodiumglucose cotransporter 2-inhibitor (SGLT2i) is due to normal increases in rates of ketogenesis but blunted increases in plasma glucose levels. In this analysis, we assessed whether rescue treatment of early ketoacidosis with insulin is altered by SGLT2i use. Research Design and Methods: Participants received 0.2 U/kg of aspart insulin after two 6-h interruptions of basal insulin that increased beta-hydroxybutyrate (BHB) by 1.2 -0.7 mmol/L before and by 1.5 -0.2 mmol/L during canagliflozin treatment. BHB and free fatty acid (FFA) were monitored every 30 min for 120 min after receiving a 0.2 U/kg subcutaneous injection of aspart insulin. Results: Ten adults (23 -5 years) were studied. During the 120 min after rescue therapy with insulin, the reductions in BHB and FFA were nearly identical between the pre-and during canagliflozin treatment studies, respectively (-1.27 -0.76 and -1.13 -0.69, P = 0.671 for BHB and -0.50 -0.35 vs. -0.41 -0.41, P = 0.603 for FFA). Conclusion: These data indicate that turning ketogenesis off, as well as on, does not appear to be affected by SGLT2i use.

A Practical Experience on the Amazon Alexa Integration in Smart Offices

“…[ 31 ] in order to help patients build up their health literacy, while in Ref. [ 32 ] to assist them in managing diabetes medication. Ref.…”

Sick day management in children and adolescents with diabetes

“…SGLT-2 inhibitors should be stopped whenever the person is feeling unwell, or ketones arise. 65,66 11 | LOW CARBOHYDRATE DIETS Low carbohydrate diets have recently gained increased popularity and, despite being controversial, are being used by children with diabetes. Clinical trials to assess their safety, efficacy and impact on diabetes-specific quality of life are ongoing.…”

“…This includes training on the use of blood ketone monitoring and counseling patients that DKA may occur without severe hyperglycemia if SGLT1/2 inhibitors are being taken. SGLT‐2 inhibitors should be stopped whenever the person is feeling unwell, or ketones arise 65,66 …”

Automated Insulin Delivery with SGLT2i Combination Therapy in Type 1 Diabetes

“… 24 On the other hand, recent data indicate that turning ketogenesis off or on is not affected by SGLT2i use. 26 SGLT2i also do not accelerate the rate of ketogenesis following interruption of basal insulin infusion in T1D. 27 …”